retatrutide trial news BREAKING NEWS: Clears Crucial Obesity TRIUMPH-1 Trial Shows Potential for

GLP-1 is an energy sensor that reduces intestinal motility, prolonging the retention of food in the gut, contributing to more efficient absorption of nutrients and better bioavailability (Winkler et al., 2019)

Is there weight related disease that warrants starting a GLP-1 medication along with lifestyle modifications, or is there time to work on lifestyle changes alone

Hard to argue with that

On average, patients in the RaeRx program lose 15-20% of their body weight

Then you increase to 7 mg daily

Know what to expect when you switch Switching from a compounded to a brand-name GLP-1 may come with a short adjustment period